Tactile Systems Technology, Inc. (NASDAQ:TCMD - Free Report) - Equities researchers at B. Riley increased their FY2024 earnings per share (EPS) estimates for shares of Tactile Systems Technology in a note issued to investors on Tuesday, November 5th. B. Riley analyst K. Bauser now anticipates that the company will earn $0.69 per share for the year, up from their previous estimate of $0.66. B. Riley currently has a "Strong-Buy" rating on the stock. The consensus estimate for Tactile Systems Technology's current full-year earnings is $0.64 per share. B. Riley also issued estimates for Tactile Systems Technology's Q4 2024 earnings at $0.33 EPS, Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.28 EPS, Q4 2025 earnings at $0.40 EPS and FY2025 earnings at $0.80 EPS.
Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.10. The firm had revenue of $73.22 million for the quarter, compared to analyst estimates of $72.62 million. Tactile Systems Technology had a net margin of 5.42% and a return on equity of 9.38%.
Several other research analysts have also weighed in on the stock. Oppenheimer lowered shares of Tactile Systems Technology from an "outperform" rating to a "market perform" rating in a research note on Tuesday. BTIG Research downgraded shares of Tactile Systems Technology from a "buy" rating to a "neutral" rating in a research note on Tuesday. Finally, StockNews.com raised Tactile Systems Technology from a "buy" rating to a "strong-buy" rating in a research note on Friday, September 20th.
Get Our Latest Stock Analysis on TCMD
Tactile Systems Technology Stock Up 8.9 %
Shares of Tactile Systems Technology stock traded up $1.19 during trading on Wednesday, reaching $14.62. The stock had a trading volume of 468,439 shares, compared to its average volume of 245,070. The stock has a fifty day moving average price of $14.07 and a two-hundred day moving average price of $13.20. The company has a current ratio of 4.44, a quick ratio of 3.89 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $347.37 million, a price-to-earnings ratio of 22.49 and a beta of 1.17. Tactile Systems Technology has a 52 week low of $9.69 and a 52 week high of $16.95.
Institutional Investors Weigh In On Tactile Systems Technology
Institutional investors and hedge funds have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD lifted its position in shares of Tactile Systems Technology by 7.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,371 shares of the company's stock valued at $283,000 after buying an additional 1,159 shares during the last quarter. Arcadia Investment Management Corp MI bought a new stake in shares of Tactile Systems Technology in the third quarter worth about $29,000. Inspire Investing LLC lifted its stake in Tactile Systems Technology by 4.3% in the first quarter. Inspire Investing LLC now owns 55,904 shares of the company's stock worth $908,000 after acquiring an additional 2,310 shares during the period. ClariVest Asset Management LLC grew its holdings in shares of Tactile Systems Technology by 2.9% during the 2nd quarter. ClariVest Asset Management LLC now owns 83,195 shares of the company's stock worth $993,000 after acquiring an additional 2,326 shares during the period. Finally, Quarry LP purchased a new position in Tactile Systems Technology during the second quarter valued at $46,000. 83.43% of the stock is owned by hedge funds and other institutional investors.
About Tactile Systems Technology
(
Get Free Report)
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
Before you consider Tactile Systems Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.
While Tactile Systems Technology currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
